Nanotechnological approaches for the effective management of psoriasis

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 6, 2016, Pages 1374-1382

  Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

drug delivery; ethosomes; liposomes; psoriasis

Indexed keywords

DERMATOLOGY; DISEASE CONTROL; DRUG DELIVERY; LIPOSOMES;

BACTERIAL INFECTIONS; CHRONIC DISORDERS; EFFECTIVE MANAGEMENT; ENVIRONMENTAL FACTORS; ETHOSOMES; PSORIASIS; PSORIATIC ARTHRITIS; SYSTEMIC APPROACH;

SKIN;

ADALIMUMAB; ALOE VERA EXTRACT; BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; BETAMETHASONE VALERATE; BORTEZOMIB; CAPSAICIN; CLOCORTOLONE PIVALATE; CYCLOSPORIN; DAPSONE; DITHRANOL; ETRETIN; GLYCYRRHIZIC ACID; KETOPROFEN; LIPOSOME; MAGNESIUM SULFATE; METHOTREXATE; MICROSPHERE; NANOCARRIER; NARINGENIN; NEEM OIL; NIOSOME; PETROLATUM; PYRITHIONE ZINC; RETINOID; SIMVASTATIN; STEROID; TOPICAL AGENT; TURMERIC; UNINDEXED DRUG;

ALOE VERA; CLINICAL TRIAL (TOPIC); DERMATOLOGIST; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERYTHRODERMIC PSORIASIS; GUTTATE PSORIASIS; HUMAN; HYDROGEL; LIPOSOMAL DELIVERY; MANIPULATIVE MEDICINE; MASSAGE; MICELLE; NAIL PSORIASIS; NANOTECHNOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REVIEW; RISK FACTOR; SKIN; STEROID THERAPY; SYSTEMIC THERAPY; CLASSIFICATION; DRUG DELIVERY SYSTEM; PROCEDURES;

DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY; PSORIASIS;

EID: 84982931982     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2015.1037885     Document Type: Review

References (107)

1. A.A.Abdelbary, M.H.AbouGhaly. 2015. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis:Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 485:235–243.
2. U.Agrawal, M.Gupta, S.P.Vyas. 2013a. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 43:33–39.
3. U.Agrawal, N.K.Mehra, U.Gupta, N.K.Jain. 2013b. Hyperbranched dendritic nano-carriers for topical delivery of dithranol. J Drug Target. 21:497–506.
4. M.F.Ali, M.Salah, M.Rafea, N.Saleh. 2008. Liposomal methotrexate hydrogel for treatment of localized psoriasis:preparation, characterization and laser targeting. Med Sci Monit. 14:PI66–74.
5. S.Z.Aydin, C.Castillo-Gallego, Z.R.Ash, H.Marzo-Ortega, P.Emery, R.J.Wakefield,. 2012. Ultrasonographic Assessment of Nail in Psoriatic Disease Shows a Link between Onychopathy and Distal Interphalangeal Joint Extensor Tendon Enthesopathy. Dermatology.225:231–235.
6. A.Azeem, M.K.Anwer, S.Talegaonkar. 2009. Niosomes in sustained and targeted drug delivery:some recent advances. J Drug Target. 17:671–689.
7. M.K.Bhalaria, S.Naik, A.N.Misra. 2009. Ethosomes:a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol. 47:368–375.
8. M.L.Bikkad, A.H.Nathani, S.K.Mandlik, S.N.Shrotriya, N.S.Ranpise. 2013. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery. J Liposome Res.24:113–123.
9. S.Chaudhary, T.Garg, R.Murthy, G.Rath, A.K.Goyal. 2015a. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. Int J Pharm. 485:108–121.
10. S.Chaudhary, T.Garg, R.S.Murthy, G.Rath, A.K.Goyal. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 22:871–872.
11. S.Chaudhary, T.Garg, G.Rath, R.R.Murthy, A.K.Goyal. 2015b. Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis. Artif Cells Nanomed Biotechnol. 1–6.
12. T.Chlapanidas, S.Perteghella, F.Leoni, S.Farago, M.Marazzi, D.Rossi,. 2014. TNF-alpha blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis. Int J Mol Sci. 15:13624–13636.
13. H.Coaker. 2012. Improved drug-delivery nanoparticles penetrate brain. Future Med Chem. 4:2135.
14. G.L.Colombo, S.Di Matteo, G.Bruno, G.Girolomoni, G.A.Vena. 2012. Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis:a cost-effectiveness analysis of the ointment versus gel formulation. Clinicoecon Outcomes Res. 4:261–268.
15. J.Q.Del Rosso, L.Kircik. 2012. A Comprehensive Review of Clocortolone Pivalate 0.1% Cream:Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses. J Clin Aesthet Dermatol. 5:20–24.
16. A.Ehrlich, S.Booher, Y.Becerra, D.L.Borris, W.D.Figg, M.L.Turner, A.Blauvelt. 2004. Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study. J Am Acad Dermatol. 50:533–540.
17. Y.P.Fang, Y.B.Huang, P.C.Wu, Y.H.Tsai. 2009. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur J Pharm Biopharm. 73:391–398.
18. N.A.Fraga, F.DE Oliveira Mde, I.Follador, O.Rocha Bde, V.R.Rego. 2012. Psoriasis and uveitis:a literature review. An Bras Dermatol. 87:877–883.
19. Gagandeep, T.Garg, B.Malik, G.Rath, A.K.Goyal. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
20. T.Garg. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
21. T.Garg, A.K.Goyal. 2012. Iontophoresis:Drug Delivery System by Applying an Electrical Potential Across the Skin. Drug Deliv Lett. 2:270–280.
22. T.Garg, A.K.Goyal. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
23. T.Garg, A.K.Goyal. 2014b. Liposomes:Targeted and Controlled Delivery System. Drug Deliv Lett. 4:62–71.
24. T.Garg, A.K.Goyal. 2014c. Medicated Chewing Gum:Patient Compliance Oral Drug Delivery System. Drug Deliv Lett. 4:72–78.
25. T.Garg, A.K.Goyal, S.Arora, R.Murthy. 2012a. Development, Optimization & Evaluation of Porous Chitosan Scaffold Formulation of Gliclazide for the Treatment of Type-2 Diabetes Mellitus. Drug Deliv Lett. 2:251–261.
26. T.Garg, A.Kumar, G.Rath, A.K.Goyal. 2014a. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst. 31:531–557.
27. T.Garg, G.Rath. 2015. Development, Optimization And Evaluation Ofelectrospun Nanofibers:Tool Fortargeted Vaginal Delivery Of Antimicrobials Against Urinary Tract Infections. Curr Drug Deliv.
28. T.Garg, G.Rath, A.K.Goyal. 2014b. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst. 31:331–364.
29. T.Garg, G.Rath, A.K.Goyal. 2014c. Biomaterials-based nanofiber scaffold:targeted and controlled carrier for cell and drug delivery. J Drug Target. 23:202–221.
30. T.Garg, G.Rath, A.K.Goyal. 2014d. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
31. T.Garg, G.Rath, A.K.Goyal. 2015. Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis. Artif Cells Nanomed Biotechnol. 1–5.
32. T.Garg, O.Singh, S.Arora, R.Murthy. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
33. T.Garg, O.Singh, S.Arora, R.Murthy. 2011b. Patented Microencapsulation Techniques And Its Application. J Pharm Res. 4:2097–2102.
34. T.Garg, O.Singh, S.Arora, R.Murthy. 2012b. Scaffold:a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
35. A.J.Gomes, C.N.Lunardi, L.O.Lunardi, D.L.Pitol, A.E.Machado. 2008. Identification of psoralen loaded PLGA microspheres in rat skin by light microscopy. Micron. 39:40–44.
36. J.S.Gordon-Elliott, P.R.Muskin. 2013. Managing the patient with psychiatric issues in dermatologic practice. Clin Dermatol. 31:3–10.
37. A.K.Goyal, G.Rath, T.Garg. 2013a. Nanotechnological Approaches for Genetic Immunization. DNA and RNA Nanobiotechnologies in Medicine:Diagnosis and Treatment of Diseases. 67–120.
38. G.Goyal, T.Garg, B.Malik, G.Chauhan, G.Rath, A.K.Goyal. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
39. G.Goyal, T.Garg, G.Rath, A.K.Goyal. 2014a. Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst. 31:89–119.
40. G.Goyal, T.Garg, G.Rath, A.K.Goyal. 2014b. Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst. 31:365–405.
41. R.Gupta, M.Gupta, S.Mangal, U.Agrawal, S.P.Vyas. 2014. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artif Cells Nanomed Biotechnol. 1–10.
42. A.Hawilo, I.Zaraa, R.Benmously, A.Mebazaa, D.EL Euch, M.Mokni, A.BEN Osman. 2011. [Erythrodermic psoriasis:epidemiological clinical and therapeutic features about 60 cases]. Tunis Med. 89:841–847.
43. D.Hazarika. 2009. Generalized pustular psoriasis of pregnancy successfully treated with cyclosporine. Indian J Dermatol Venereol Leprol. 75:638.
44. N.D.Henley. 2012. Rapid-onset skin rash. Guttate psoriasis. Am Fam Physician. 86:361–362.
45. T.Hussain, T.Garg, A.K.Goyal, G.Rath. 2014. Biomedical Applications of Nanofiber Scaffolds in Tissue Engineering. J Biomater Tissue Eng. 4:600–623.
46. K.R.Jadhav, I.M.Shaikh, K.W.Ambade, V.J.Kadam. 2006. Applications of microemulsion based drug delivery system. Curr Drug Deliv. 3:267–273.
47. H.S.Johal, T.Garg, G.Rath, A.K.Goyal. 2014. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 1–14.
48. D.Joshi, T.Garg, A.K.Goyal, G.Rath. 2014a. Advanced drug delivery approaches against periodontitis. Drug Deliv. 1–15.
49. D.Joshi, T.Garg, A.K.Goyal, G.Rath. 2014b. Development and Characterization of Novel Medicated Nanofibers against Periodontitis. Curr Drug Deliv.
50. V.Kalia, T.Garg, G.Rath, A.K.Goyal. 2014. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. 1–5.
51. K.Kataria, A.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014. Novel Technology to Improve Drug Loading in Polymeric Nanofibers. Drug Deliv Lett. 4:79–86.
52. M.Kato. 2012. [Development of photodegradable nanoparticle for phototherapy]. Yakugaku Zasshi. 132:201–204.
53. G.Kaur, T.Garg, G.Rath, A.K.Goyal. 2015a. Archaeosomes:an excellent carrier for drug and cell delivery. Drug Deliv. 1–16.
54. M.Kaur, T.Garg, R.K.Narang. 2014a. A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. 1–7.
55. M.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014b. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31:49–88.
56. M.Kaur, B.Malik, T.Garg, G.Rath, A.K.Goyal. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
57. N.Kaur, T.Garg, A.K.Goyal, G.Rath. 2014d. Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. 1–10.
58. P.Kaur, T.Garg, G.Rath, A.K.Goyal. 2015b. In situ nasal gel drug delivery:A novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol. 1–10.
59. P.Kaur, T.Garg, G.Rath, R.S.Murthy, A.K.Goyal. 2014e. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. 1–14.
60. P.Kaur, T.Garg, G.Rath, R.S.Murthy, A.K.Goyal. 2014f. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 1–12.
61. P.Kaur, T.Garg, B.Vaidya, A.Prakash, G.Rath, A.K.Goyal. 2014g. Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug:behavioral and biochemical assessment. J Drug Target. 1–12.
62. R.Kaur, T.Garg, U.DAS Gupta, P.Gupta, G.Rath, A.K.Goyal. 2014h. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
63. R.Kaur, T.Garg, B.Malik, U.D.Gupta, P.Gupta, G.Rath, A.K.Goyal. 2014i. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. 1–6.
64. R.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014j. Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst. 31:495–530.
65. V.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014k. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 1–12.
66. N.O.Knudsen, S.Ronholt, R.D.Salte, L.Jorgensen, T.Thormann, L.H.Basse, J.Hansen, S.Frokjaer, C.Foged. 2012. Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm. 81:532–539.
67. A.Kumar, T.Garg, G.S.Sarma, G.Rath, A.K.Goyal. 2015. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design. Eur J Pharm Sci. 70C:140–151.
68. P.K.Lakshmi, G.S.Devi, S.Bhaskaran, S.Sacchidanand. 2007. Niosomal methotrexate gel in the treatment of localized psoriasis:phase I and phase II studies. Indian J Dermatol Venereol Leprol. 73:157–161.
69. S.Lee, C.I.Coleman, B.Limone, R.Kaur, C.M.White, J.Kluger, D.M.Sobieraj. 2012. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis. Rockville (MD).
70. L.L.Lin, J.E.Grice, M.K.Butler, A.V.Zvyagin, W.Becker, T.A.Robertson,. 2011. Time-correlated single photon counting for simultaneous monitoring of zinc oxide nanoparticles and NAD(P)H in intact and barrier-disrupted volunteer skin. Pharm Res. 28:2920–2930.
71. A.K.Mahapatra, P.N.Murthy, S.Samoju, A.K.Mohapatra. 2014. Tiny technology proves big:a challenge at engineering, medicine and pharmaceutical sciences interface. Crit Rev Ther Drug Carrier Syst. 31:1–47.
72. R.Malik, T.Garg, A.K.Goyal, G.Rath. 2014. Polymeric nanofibers:targeted gastro-retentive drug delivery systems. J Drug Target. 23:109–124.
73. C.Marianecci, F.Rinaldi, M.Mastriota, S.Pieretti, E.Trapasso, D.Paolino, M.Carafa. 2012. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system:human and murine models. J Control Release. 164:17–25.
74. H.Marwah, T.Garg, A.K.Goyal, G.Rath. 2014. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 1–15.
75. P.Mease. 2012. Update on treatment of psoriatic arthritis. Bull NYU Hosp Jt Dis. 70:167–171.
76. M.Miroddi, M.Navarra, F.Calapai, F.Mancari, S.V.Giofre, S.Gangemi, G.Calapai. 2015. Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis. Phytother Res. doi:10.1002/ptr.5316
77. V.Modgill, T.Garg, A.K.Goyal, G.Rath. 2014a. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 1–6.
78. V.Modgill, T.Garg, A.K.Goyal, G.Rath. 2014b. Transmucosal Delivery of Linagliptin for the Treatment of Type- 2 Diabetes Mellitus by Ultra-Thin Nanofibers. Curr Drug Deliv.
79. A.Morie, T.Garg, A.K.Goyal, G.Rath. 2014. Nanofibers as novel drug carrier - An overview. Artif Cells Nanomed Biotechnol. 1–9.
80. S.Pabreja, T.Garg, G.Rath, A.K.Goyal. 2014. Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. 1–8.
81. K.K.Park, F.Kamangar, M.Heller, E.Lee, T.Bhutani, K.Busse,. 2013. Instant barrier repair:A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis. J Dermatolog Treat. 24:119–121.
82. R.B.Patel, R.H.Parikh. 2012. Preparation and formulation of transferosomes containing an antifungal agent for transdermal delivery:Application of Plackett-Burman design to identify significant factors influencing vesicle size. J Pharm Bioallied Sci. 4:S60–61.
83. T.Patel, T.Bhutani, K.L.Busse, J.Koo. 2011. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch:a 6-week bilaterally controlled, investigator-blinded trial. Cutis. 88:149–154.
84. A.Picardi, I.Lega, E.Tarolla. 2013. Suicide risk in skin disorders. Clin Dermatol. 31:47–56.
85. M.Pradhan, D.Singh, M.R.Singh. 2014. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders. Artif Cells Nanomed Biotechnol. 1–9.
86. R.Rajan, S.Jose, V.P.Mukund, D.T.Vasudevan. 2011. Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2:138–143.
87. R.Rohilla, T.Garg, J.Bariwal, A.K.Goyal, G.Rath. 2014a. Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. 1–8.
88. R.Rohilla, T.Garg, A.K.Goyal, G.Rath. 2014b. Herbal and polymeric approaches for liver-targeting drug delivery:novel strategies and their significance. Drug Deliv. 1–17.
89. D.K.Sarker. 2005. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv. 2:297–310.
90. A.Sharma, T.Garg, A.Aman, K.Panchal, R.Sharma, S.Kumar, T.Markandeywar. 2014a. Nanogel-an advanced drug delivery tool:Current and future. Artif Cells Nanomed Biotechnol. 1–13.
91. A.K.Sharma, T.Garg, A.K.Goyal, G.Rath. 2015. Role of microemuslsions in advanced drug delivery. Artif Cells Nanomed Biotechnol. 1–9.
92. R.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber:A tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
93. R.Sharma, H.Singh, M.Joshi, A.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014c. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst. 31:187–217.
94. B.Singh, T.Garg, A.K.Goyal, G.Rath. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
95. H.Singh, R.Sharma, M.Joshi, T.Garg, A.K.Goyal, G.Rath. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
96. K.Singh, N.Arora, T.Garg. 2012a. RFID:A Trustable Security Tool in Pharmaceutical Industry. Am J Pharm Tech Res. 2:113–127.
97. K.Singh, N.Arora, T.Garg. 2012b. Superbug:Antimicrobial resistance due to NDM-1. Int J Institut Pharm life sci. 2:58–66.
98. O.Singh, T.Garg, G.Rath, A.K.Goyal. 2014c. Microbicides for the treatment of sexually transmitted hiv infections. J Pharmaceutics. 1–18.
99. P.Srisuk, P.Thongnopnua, U.Raktanonchai, S.Kanokpanont. 2012. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm. 427:426–434.
100. Z.U.Syed, A.Khachemoune. 2011. Inverse psoriasis:case presentation and review. Am J Clin Dermatol. 12:143–146.
101. G.Tarun, S.Onkar, A.Saahil, M.Rsr. 2011. Journal of Pharmacy Research. Patented microencapsulation techniques and its applications. 4:2097–2102.
102. M.C.Valerii, M.Benaglia, C.Caggiano, A.Papi, A.Strillacci, G.Lazzarini,. 2013. Drug delivery by polymeric micelles:an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon. Nanomedicine. 9:675–685.
103. M.Viguier, F.Aubin, E.Delaporte, C.Pages, C.Paul, M.Beylot-Barry,. 2012. Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Acute Generalized Pustular Psoriasis. Arch Dermatol. 148:1423–1425.
104. Z.Wang, Y.Itoh, Y.Hosaka, I.Kobayashi, Y.Nakano, I.Maeda,. 2003. Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. J Biosci Bioeng. 95:541–543.
105. A.Z.Wilczewska, K.Niemirowicz, K.H.Markiewicz, H.Car. 2012. Nanoparticles as drug delivery systems. Pharmacol Rep. 64:1020–1037.
106. H.Xiong, Y.Xu, G.Tan, Y.Han, Z.Tang, W.Xu,. 2015. Glycyrrhizin Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice and Inhibits TNF-alpha-Induced ICAM-1 Expression via NF-kappaB/MAPK in HaCaT Cells. Cell Physiol Biochem. 35:1335–1346.
107. Y.T.Zhang, L.N.Shen, Z.H.Wu, J.H.Zhao, N.P.Feng. 2014. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 471:449–452.